Genesis Consortium
Meet the unqiue investing entities that originated at SOSV and remain closely aligned with our fund.
SOSV Consortium Members
SOSV’s IndieBio and venture fund Mayfield created the consortium as an alliance of venture corporations and funds committed to advancing human and planetary health.
The goal is to provide a strong foundation for life science entrepreneurs, the early stage venture ecosystem, and society at large.
We invite those committed to life science investing to join the Genesis Consortium. In addition to SOSV and Mayfield, current members include venture funds DCVC, Litani and Salt and corporate VCs at ADM and Solvay.
The Genesis Consortium works with IndieBio to produce regular in-person events on life sciences investing at IndieBio’s events spaces in San Francisco and New York City. In addition, the consortium participates in SOSV’s annual Climate Tech Summit.
The Genesis Consortium enables a greater range of VCs and corporates to invest more actively in the future of human and planetary health. We provide a strong foundation for life science entrepreneurs, the early stage venture ecosystem, and society at large.
dlab is a startup development program and venture studio exploring new topics in decentralization and blockchain technology.
In January 2023, dlab became spun out of SOSV. Former SOSV GP Shawn Broderick and former SOSV partner Nick Plante are the general partners in the new fund. SOSV is dlab’s anchor limited partner.
Broderick and Plante launched the dlab in 2019 to work with carefully selected founders delving into Web3, decentralization, and the blockchain. Their goal was to find the earliest-stage startups that would build the infrastructure necessary to realize the vast ambitions of the Web3 universe.
Despite the swings endemic to the crypto side of blockchain, dlab’s Web3 thesis has proven out well. Prior to dlab’s separation, SOSV invested in 23 dlab startups, including: API3, building first-party oracles to bring data on-chain via trustless apps, Contango, creating a decentralized exchange for expirables without order books or liquidity pools Composable Finance, engineering trustless cross-chain interoperability.
To learn more, visit dlab.
Orbit Startups helps startups with breakthrough technologies reach global scale by expanding across emerging and frontier markets.
In November 2023, Orbit became an independent fund with SOSV as its anchor limited partner. Former SOSV general partners William Bao Bean and Oscar Ramos are the founding general partners of Orbit Startups, which has offices in Taipei and Shanghai.
The fund originated at SOSV in 2022 as the successor to SOSV’s Chinaccelerator, which started in 2010 and was Asia’s first startup accelerator. Orbit also incorporated the accelerator MOX, which launched in Taipei in 2015.
Orbit backs tech players that can impact millions of lives at once—startups that are solving monumental problems in healthcare, climate, education, finance, and logistics.
Orbit provides early stage (up to series A) founders the opportunity to work virtually or in-person with Orbit’s growth experts. Orbit provides $150,000 in capital and introductions to raise follow-on rounds. Orbit conducts four cohorts each year with approximately 10 companies in each.
The Orbit portfolio includes companies based in more than 30 countries with particular focus on startups operating in Asia, the Middle East, Africa, the Americas, and other emerging markets.
Among the best known companies in the Orbit portfolio are VideoVerse, Elsa, Octopus, BitMEX and Dastgyr.
Visit Orbit Startups.
Get in Touch
If you want to be part of the SOSV Consortium or would like to get more info about what we’re building, please fill up the form and we’ll be in touch soon.
We don’t spam. Our Privacy Statement and Terms of Use apply.